Update on methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity
1University of Maryland School of Pharmacy, Baltimore, MD, USA.
Summary
This review evaluates extended-release methylphenidate and dexmethylphenidate formulations for attention-deficit/hyperactivity disorder (ADHD). Understanding formulation differences is key for effective ADHD treatment and symptom management.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Pharmacy
Background:
- Methylphenidate is a primary treatment for ADHD.
- Short half-life necessitates extended-release formulations.
- Various intermediate- and long-acting products exist.
Purpose of the Study:
- Evaluate current literature on safety and efficacy.
- Assess intermediate- and long-acting methylphenidate/dexmethylphenidate formulations for ADHD.
- Provide guidance on medication selection.
Main Methods:
- Literature review of existing studies.
- Analysis of pharmacokinetic and adverse effect data.
- Comparison of different extended-release mechanisms.
Main Results:
- Extended-release products show similar efficacy to immediate-acting forms.
- Pharmacokinetics and adverse effects vary among formulations.
- Some intermediate-acting products still require twice-daily dosing.
- Long-acting products include novel delivery systems (controlled-release, bimodal, patch).
Conclusions:
- Knowledge of methylphenidate/dexmethylphenidate formulations is vital for ADHD treatment.
- Understanding release mechanisms and pharmacokinetics aids appropriate product selection.
- Optimizing ADHD symptom control relies on informed medication choices.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.0K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.6K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
498
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
498
01:28Adrenergic Agonists: Mixed-Action Agents
1.1K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.1K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
462
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
462
01:30Adrenergic Agonists: Therapeutic Uses
1.3K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.3K
01:29Drug Dosing: Infants and Children
71
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
71
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.6K